C. Renoux

First name
C.
Last name
Renoux
Simms-Williams, N., Treves, N., Yin, H., Lu, S., Yu, O., Pradhan, R., et al. (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242
Douros, A., Ante, Z., Fallone, C. A., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2024). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study. Alzheimers Dement, 20, 1716-1724. http://doi.org/10.1002/alz.13561
Rahman, A. A., Platt, R. W., Beradid, S., Boivin, J. F., Rej, S., & Renoux, C. (2024). Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding. Jama Netw Open, 7, e243208. http://doi.org/10.1001/jamanetworkopen.2024.3208
Chiv, R., Beradid, S., Suissa, S., & Renoux, C. (2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke. http://doi.org/10.1161/strokeaha.123.045098
Engler, J., Filliter, C., Montastruc, F., Abenhaim, H., Rej, S., & Renoux, C. (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813-821. http://doi.org/10.1016/j.jad.2024.01.163
Douros, A., Ante, Z., Fallone, C. A., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2023). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study. Alzheimers Dement. http://doi.org/10.1002/alz.13561
Dimakos, J., Cui, Y., Platt, R. W., Renoux, C., Filion, K. B., & Douros, A. (2023). Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2975
Suissa, S., Dell'Aniello, S., & Renoux, C. (2023). The prevalent new-user design for studies with no active comparator: The example of statins and cancer. Epidemiology. http://doi.org/10.1097/ede.0000000000001628
Coulombe, J., Moodie, E. E., Shortreed, S. M., & Renoux, C. (2023). Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times. Stat Methods Med Res, 9622802231158733. http://doi.org/10.1177/09622802231158733
Dimakos, J., Cui, Y., Platt, R. W., Renoux, C., Filion, K. B., & Douros, A. (2022). Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1584